The present study revealed that TRAIL-resistance due to hypermethylation of the DR4 and DR5 genes is unlikely in the majority of BCP-ALL cases, particularly in the cases with favorable karyotypes such as hyperdiploidy and ETV6-RUNX1. The gene discussed is TNFRSF10B; the disease is acute lymphoblastic leukemia.